ヒトパピローマウイルスワクチンの世界市場（～2026年）

• 英文タイトル：Global Human Papillomavirus Vaccine Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01432 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はヒトパピローマウイルスワクチンのグローバル市場について調査・分析したレポートです。種類別（二価、四価、一価）市場規模、用途別（医師、卸売業者、医師販売代理店、政府機関、公的・私的同盟）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトパピローマウイルスワクチンの競争状況、市場シェア ・世界のヒトパピローマウイルスワクチン市場：種類別市場規模 2015年-2020年（二価、四価、一価） ・世界のヒトパピローマウイルスワクチン市場：種類別市場規模予測 2021年-2026年（二価、四価、一価） ・世界のヒトパピローマウイルスワクチン市場：用途別市場規模 2015年-2020年（医師、卸売業者、医師販売代理店、政府機関、公的・私的同盟） ・世界のヒトパピローマウイルスワクチン市場：用途別市場規模予測 2021年-2026年（医師、卸売業者、医師販売代理店、政府機関、公的・私的同盟） ・北米のヒトパピローマウイルスワクチン市場分析：米国、カナダ ・ヨーロッパのヒトパピローマウイルスワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトパピローマウイルスワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトパピローマウイルスワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトパピローマウイルスワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、GlaxoSmithKline、Sanofi、Johnson & Johnson、AstraZeneca、Serum Institute、Wantai Biological、KM Biologics、Bharat Biotech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus.

Market Analysis and Insights: Global Human Papillomavirus Vaccine Market
The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2154.7 million in 2020, at a CAGR of 2.8%% during 2021-2026.

Global Human Papillomavirus Vaccine Scope and Market Size
Human Papillomavirus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Papillomavirus Vaccine market is segmented into
Bivalent
Quadrivalent
Nonavalent

Segment by Application, the Human Papillomavirus Vaccine market is segmented into
Physicians
Wholesalers
Physician Distributors
Government Entities
Public and Private Alliances

Regional and Country-level Analysis
The Human Papillomavirus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Papillomavirus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Papillomavirus Vaccine Market Share Analysis
Human Papillomavirus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Papillomavirus Vaccine business, the date to enter into the Human Papillomavirus Vaccine market, Human Papillomavirus Vaccine product introduction, recent developments, etc.

The major vendors covered:
Merck
GlaxoSmithKline
Sanofi
Johnson & Johnson
AstraZeneca
Serum Institute
Wantai Biological
KM Biologics
Bharat Biotech

レポート目次

---

1 Study Coverage
1.1 Human Papillomavirus Vaccine Product Introduction
1.2 Market Segments
1.3 Key Human Papillomavirus Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Papillomavirus Vaccine Market Size Growth Rate by Type
1.4.2 Bivalent
1.4.3 Quadrivalent
1.4.4 Nonavalent
1.5 Market by Application
1.5.1 Global Human Papillomavirus Vaccine Market Size Growth Rate by Application
1.5.2 Physicians
1.5.3 Wholesalers
1.5.4 Physician Distributors
1.5.5 Government Entities
1.5.6 Public and Private Alliances
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Papillomavirus Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Human Papillomavirus Vaccine Revenue 2015-2026
2.1.2 Global Human Papillomavirus Vaccine Sales 2015-2026
2.2 Global Human Papillomavirus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Papillomavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Papillomavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Papillomavirus Vaccine Competitor Landscape by Players
3.1 Human Papillomavirus Vaccine Sales by Manufacturers
3.1.1 Human Papillomavirus Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Human Papillomavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Human Papillomavirus Vaccine Revenue by Manufacturers
3.2.1 Human Papillomavirus Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Human Papillomavirus Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Papillomavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Papillomavirus Vaccine Revenue in 2019
3.2.5 Global Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Papillomavirus Vaccine Price by Manufacturers
3.4 Human Papillomavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Papillomavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Papillomavirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Papillomavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Human Papillomavirus Vaccine Market Size by Type (2015-2020)
4.1.1 Global Human Papillomavirus Vaccine Sales by Type (2015-2020)
4.1.2 Global Human Papillomavirus Vaccine Revenue by Type (2015-2020)
4.1.3 Human Papillomavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Papillomavirus Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Papillomavirus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Human Papillomavirus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Human Papillomavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Papillomavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Human Papillomavirus Vaccine Market Size by Application (2015-2020)
5.1.1 Global Human Papillomavirus Vaccine Sales by Application (2015-2020)
5.1.2 Global Human Papillomavirus Vaccine Revenue by Application (2015-2020)
5.1.3 Human Papillomavirus Vaccine Price by Application (2015-2020)
5.2 Human Papillomavirus Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Papillomavirus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Human Papillomavirus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Papillomavirus Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Human Papillomavirus Vaccine by Country
6.1.1 North America Human Papillomavirus Vaccine Sales by Country
6.1.2 North America Human Papillomavirus Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Papillomavirus Vaccine Market Facts & Figures by Type
6.3 North America Human Papillomavirus Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Human Papillomavirus Vaccine by Country
7.1.1 Europe Human Papillomavirus Vaccine Sales by Country
7.1.2 Europe Human Papillomavirus Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Papillomavirus Vaccine Market Facts & Figures by Type
7.3 Europe Human Papillomavirus Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Human Papillomavirus Vaccine by Region
8.1.1 Asia Pacific Human Papillomavirus Vaccine Sales by Region
8.1.2 Asia Pacific Human Papillomavirus Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Papillomavirus Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Human Papillomavirus Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Human Papillomavirus Vaccine by Country
9.1.1 Latin America Human Papillomavirus Vaccine Sales by Country
9.1.2 Latin America Human Papillomavirus Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Papillomavirus Vaccine Market Facts & Figures by Type
9.3 Central & South America Human Papillomavirus Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Human Papillomavirus Vaccine by Country
10.1.1 Middle East and Africa Human Papillomavirus Vaccine Sales by Country
10.1.2 Middle East and Africa Human Papillomavirus Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Papillomavirus Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Human Papillomavirus Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Human Papillomavirus Vaccine Products Offered
11.1.5 Merck Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Human Papillomavirus Vaccine Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Human Papillomavirus Vaccine Products Offered
11.3.5 Sanofi Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Human Papillomavirus Vaccine Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Human Papillomavirus Vaccine Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Serum Institute
11.6.1 Serum Institute Corporation Information
11.6.2 Serum Institute Description and Business Overview
11.6.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Serum Institute Human Papillomavirus Vaccine Products Offered
11.6.5 Serum Institute Related Developments
11.7 Wantai Biological
11.7.1 Wantai Biological Corporation Information
11.7.2 Wantai Biological Description and Business Overview
11.7.3 Wantai Biological Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Wantai Biological Human Papillomavirus Vaccine Products Offered
11.7.5 Wantai Biological Related Developments
11.8 KM Biologics
11.8.1 KM Biologics Corporation Information
11.8.2 KM Biologics Description and Business Overview
11.8.3 KM Biologics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 KM Biologics Human Papillomavirus Vaccine Products Offered
11.8.5 KM Biologics Related Developments
11.9 Bharat Biotech
11.9.1 Bharat Biotech Corporation Information
11.9.2 Bharat Biotech Description and Business Overview
11.9.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bharat Biotech Human Papillomavirus Vaccine Products Offered
11.9.5 Bharat Biotech Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Human Papillomavirus Vaccine Products Offered
11.1.5 Merck Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Papillomavirus Vaccine Market Estimates and Projections by Region
12.1.1 Global Human Papillomavirus Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Human Papillomavirus Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Human Papillomavirus Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Human Papillomavirus Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Human Papillomavirus Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Human Papillomavirus Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Human Papillomavirus Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Human Papillomavirus Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Human Papillomavirus Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Human Papillomavirus Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Papillomavirus Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Papillomavirus Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Papillomavirus Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Papillomavirus Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Papillomavirus Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Papillomavirus Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Human Papillomavirus Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Papillomavirus Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Papillomavirus Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Papillomavirus Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Papillomavirus Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Papillomavirus Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Papillomavirus Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Papillomavirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Human Papillomavirus Vaccine Market Segments
Table 2. Ranking of Global Top Human Papillomavirus Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Papillomavirus Vaccine Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Bivalent
Table 5. Major Manufacturers of Quadrivalent
Table 6. Major Manufacturers of Nonavalent
Table 7. Global Human Papillomavirus Vaccine Market Size Growth Rate by Application 2020-2026 (Kg)
Table 8. Global Human Papillomavirus Vaccine Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 9. Global Human Papillomavirus Vaccine Sales by Regions 2015-2020 (Kg)
Table 10. Global Human Papillomavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 11. Global Human Papillomavirus Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Human Papillomavirus Vaccine Sales by Manufacturers (2015-2020) (Kg)
Table 13. Global Human Papillomavirus Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Human Papillomavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Human Papillomavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Vaccine as of 2019)
Table 16. Human Papillomavirus Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Human Papillomavirus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Human Papillomavirus Vaccine Price (2015-2020) (USD/Kg)
Table 19. Human Papillomavirus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Human Papillomavirus Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Human Papillomavirus Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 24. Global Human Papillomavirus Vaccine Sales Share by Type (2015-2020)
Table 25. Global Human Papillomavirus Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Human Papillomavirus Vaccine Revenue Share by Type (2015-2020)
Table 27. Human Papillomavirus Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 28. Global Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 29. Global Human Papillomavirus Vaccine Sales Share by Application (2015-2020)
Table 30. North America Human Papillomavirus Vaccine Sales by Country (2015-2020) (Kg)
Table 31. North America Human Papillomavirus Vaccine Sales Market Share by Country (2015-2020)
Table 32. North America Human Papillomavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Human Papillomavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 34. North America Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 35. North America Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Table 36. North America Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 37. North America Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Table 38. Europe Human Papillomavirus Vaccine Sales by Country (2015-2020) (Kg)
Table 39. Europe Human Papillomavirus Vaccine Sales Market Share by Country (2015-2020)
Table 40. Europe Human Papillomavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Human Papillomavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 42. Europe Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 43. Europe Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Table 44. Europe Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 45. Europe Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Human Papillomavirus Vaccine Sales by Region (2015-2020) (Kg)
Table 47. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Human Papillomavirus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Human Papillomavirus Vaccine Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 51. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 53. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Table 54. Latin America Human Papillomavirus Vaccine Sales by Country (2015-2020) (Kg)
Table 55. Latin America Human Papillomavirus Vaccine Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Human Papillomavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Human Papillomavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Latin America Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 59. Latin America Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Table 60. Latin America Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 61. Latin America Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2015-2020) (Kg)
Table 63. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Human Papillomavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Human Papillomavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human Papillomavirus Vaccine Sales by Type (2015-2020) (Kg)
Table 67. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2015-2020) (Kg)
Table 69. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Table 70. Merck Corporation Information
Table 71. Merck Description and Major Businesses
Table 72. Merck Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 73. Merck Product
Table 74. Merck Recent Development
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Major Businesses
Table 82. Sanofi Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Sanofi Product
Table 84. Sanofi Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Major Businesses
Table 92. AstraZeneca Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. AstraZeneca Product
Table 94. AstraZeneca Recent Development
Table 95. Serum Institute Corporation Information
Table 96. Serum Institute Description and Major Businesses
Table 97. Serum Institute Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Serum Institute Product
Table 99. Serum Institute Recent Development
Table 100. Wantai Biological Corporation Information
Table 101. Wantai Biological Description and Major Businesses
Table 102. Wantai Biological Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Wantai Biological Product
Table 104. Wantai Biological Recent Development
Table 105. KM Biologics Corporation Information
Table 106. KM Biologics Description and Major Businesses
Table 107. KM Biologics Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. KM Biologics Product
Table 109. KM Biologics Recent Development
Table 110. Bharat Biotech Corporation Information
Table 111. Bharat Biotech Description and Major Businesses
Table 112. Bharat Biotech Human Papillomavirus Vaccine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Bharat Biotech Product
Table 114. Bharat Biotech Recent Development
Table 115. Global Human Papillomavirus Vaccine Sales Forecast by Regions (2021-2026) (Kg)
Table 116. Global Human Papillomavirus Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Human Papillomavirus Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Human Papillomavirus Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Human Papillomavirus Vaccine Sales Forecast by Country (2021-2026) (Kg)
Table 120. North America: Human Papillomavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Human Papillomavirus Vaccine Sales Forecast by Country (2021-2026) (Kg)
Table 122. Europe: Human Papillomavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Human Papillomavirus Vaccine Sales Forecast by Region (2021-2026) (Kg)
Table 124. Asia Pacific: Human Papillomavirus Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Human Papillomavirus Vaccine Sales Forecast by Country (2021-2026) (Kg)
Table 126. Latin America: Human Papillomavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Human Papillomavirus Vaccine Sales Forecast by Country (2021-2026) (Kg)
Table 128. Middle East and Africa: Human Papillomavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Human Papillomavirus Vaccine Players
Table 133. Human Papillomavirus Vaccine Customers List
Table 134. Human Papillomavirus Vaccine Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Vaccine Product Picture
Figure 2. Global Human Papillomavirus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Bivalent Product Picture
Figure 4. Quadrivalent Product Picture
Figure 5. Nonavalent Product Picture
Figure 6. Global Human Papillomavirus Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Physicians
Figure 8. Wholesalers
Figure 9. Physician Distributors
Figure 10. Government Entities
Figure 11. Public and Private Alliances
Figure 12. Human Papillomavirus Vaccine Report Years Considered
Figure 13. Global Human Papillomavirus Vaccine Market Size 2015-2026 (US$ Million)
Figure 14. Global Human Papillomavirus Vaccine Sales 2015-2026 (Kg)
Figure 15. Global Human Papillomavirus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Human Papillomavirus Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Human Papillomavirus Vaccine Sales Market Share by Region in 2019
Figure 18. Global Human Papillomavirus Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Human Papillomavirus Vaccine Revenue Market Share by Region in 2019
Figure 20. Global Human Papillomavirus Vaccine Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Human Papillomavirus Vaccine Revenue in 2019
Figure 22. Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Human Papillomavirus Vaccine Sales Market Share by Type (2015-2020)
Figure 24. Global Human Papillomavirus Vaccine Sales Market Share by Type in 2019
Figure 25. Global Human Papillomavirus Vaccine Revenue Market Share by Type (2015-2020)
Figure 26. Global Human Papillomavirus Vaccine Revenue Market Share by Type in 2019
Figure 27. Global Human Papillomavirus Vaccine Market Share by Price Range (2015-2020)
Figure 28. Global Human Papillomavirus Vaccine Sales Market Share by Application (2015-2020)
Figure 29. Global Human Papillomavirus Vaccine Sales Market Share by Application in 2019
Figure 30. Global Human Papillomavirus Vaccine Revenue Market Share by Application (2015-2020)
Figure 31. Global Human Papillomavirus Vaccine Revenue Market Share by Application in 2019
Figure 32. North America Human Papillomavirus Vaccine Sales Growth Rate 2015-2020 (Kg)
Figure 33. North America Human Papillomavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Human Papillomavirus Vaccine Sales Market Share by Country in 2019
Figure 35. North America Human Papillomavirus Vaccine Revenue Market Share by Country in 2019
Figure 36. U.S. Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 37. U.S. Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 39. Canada Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Human Papillomavirus Vaccine Market Share by Type in 2019
Figure 41. North America Human Papillomavirus Vaccine Market Share by Application in 2019
Figure 42. Europe Human Papillomavirus Vaccine Sales Growth Rate 2015-2020 (Kg)
Figure 43. Europe Human Papillomavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Human Papillomavirus Vaccine Sales Market Share by Country in 2019
Figure 45. Europe Human Papillomavirus Vaccine Revenue Market Share by Country in 2019
Figure 46. Germany Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 47. Germany Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 49. France Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 51. U.K. Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 53. Italy Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 55. Russia Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Human Papillomavirus Vaccine Market Share by Type in 2019
Figure 57. Europe Human Papillomavirus Vaccine Market Share by Application in 2019
Figure 58. Asia Pacific Human Papillomavirus Vaccine Sales Growth Rate 2015-2020 (Kg)
Figure 59. Asia Pacific Human Papillomavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Human Papillomavirus Vaccine Revenue Market Share by Region in 2019
Figure 62. China Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 63. China Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 65. Japan Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 67. South Korea Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 69. India Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 71. Australia Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 73. Taiwan Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 75. Indonesia Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 77. Thailand Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 79. Malaysia Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 81. Philippines Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 83. Vietnam Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Human Papillomavirus Vaccine Market Share by Type in 2019
Figure 85. Asia Pacific Human Papillomavirus Vaccine Market Share by Application in 2019
Figure 86. Latin America Human Papillomavirus Vaccine Sales Growth Rate 2015-2020 (Kg)
Figure 87. Latin America Human Papillomavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Human Papillomavirus Vaccine Sales Market Share by Country in 2019
Figure 89. Latin America Human Papillomavirus Vaccine Revenue Market Share by Country in 2019
Figure 90. Mexico Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 91. Mexico Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 93. Brazil Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 95. Argentina Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Human Papillomavirus Vaccine Market Share by Type in 2019
Figure 97. Latin America Human Papillomavirus Vaccine Market Share by Application in 2019
Figure 98. Middle East and Africa Human Papillomavirus Vaccine Sales Growth Rate 2015-2020 (Kg)
Figure 99. Middle East and Africa Human Papillomavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Human Papillomavirus Vaccine Revenue Market Share by Country in 2019
Figure 102. Turkey Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 103. Turkey Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 105. Saudi Arabia Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Human Papillomavirus Vaccine Sales Growth Rate (2015-2020) (Kg)
Figure 107. U.A.E Human Papillomavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Human Papillomavirus Vaccine Market Share by Type in 2019
Figure 109. Middle East and Africa Human Papillomavirus Vaccine Market Share by Application in 2019
Figure 110. North America Human Papillomavirus Vaccine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 111. North America Human Papillomavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Human Papillomavirus Vaccine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 113. Europe Human Papillomavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Human Papillomavirus Vaccine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 115. Asia Pacific Human Papillomavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Human Papillomavirus Vaccine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. Latin America Human Papillomavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Human Papillomavirus Vaccine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Middle East and Africa Human Papillomavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---